EMT factors and metabolic pathways in cancer

I Georgakopoulos-Soares, DV Chartoumpekis… - Frontiers in …, 2020 - frontiersin.org
The epithelial-mesenchymal transition (EMT) represents a biological program during which
epithelial cells lose their cell identity and acquire a mesenchymal phenotype. EMT is …

The epithelial–mesenchymal transition at the crossroads between metabolism and tumor progression

M Fedele, R Sgarra, S Battista, L Cerchia… - International journal of …, 2022 - mdpi.com
The transition between epithelial and mesenchymal phenotype is emerging as a key
determinant of tumor cell invasion and metastasis. It is a plastic process in which epithelial …

Post-translational modifications reshape the antigenic landscape of the MHC I immunopeptidome in tumors

A Kacen, A Javitt, MP Kramer, D Morgenstern… - Nature …, 2023 - nature.com
Post-translational modification (PTM) of antigens provides an additional source of
specificities targeted by immune responses to tumors or pathogens, but identifying antigen …

Targeting ferroptosis in breast cancer

Z Li, L Chen, C Chen, Y Zhou, D Hu, J Yang, Y Chen… - Biomarker …, 2020 - Springer
Ferroptosis is a recently discovered distinct type of regulated cell death caused by the
accumulation of lipid-based ROS. Metabolism and expression of specific genes affect the …

[HTML][HTML] Sulfasalazine‑induced ferroptosis in breast cancer cells is reduced by the inhibitory effect of estrogen receptor on the transferrin receptor

H Yu, C Yang, L Jian, S Guo, R Chen… - Oncology …, 2019 - spandidos-publications.com
The aim of the present study was to clarify the activation of ferroptosis in different breast
cancer cells by sulfasalazine (SAS) and to explore the relationship between the estrogen …

Synthetic lethal combination targeting BET uncovered intrinsic susceptibility of TNBC to ferroptosis

N Verma, Y Vinik, A Saroha, NU Nair, E Ruppin… - Science …, 2020 - science.org
Identification of targeted therapies for TNBC is an urgent medical need. Using a drug
combination screen reliant on synthetic lethal interactions, we identified clinically relevant …

Elucidating cancer metabolic plasticity by coupling gene regulation with metabolic pathways

D Jia, M Lu, KH Jung, JH Park, L Yu… - Proceedings of the …, 2019 - National Acad Sciences
Metabolic plasticity enables cancer cells to switch their metabolism phenotypes between
glycolysis and oxidative phosphorylation (OXPHOS) during tumorigenesis and metastasis …

Ferroptosis: An emerging approach for targeting cancer stem cells and drug resistance

SM Elgendy, SK Alyammahi, DW Alhamad… - Critical Reviews in …, 2020 - Elsevier
Resistance to chemotherapeutic agents remains a major challenge in the fierce battle
against cancer. Cancer stem cells (CSCs) are a small population of cells in tumors that …

Recent treatment progress of triple negative breast cancer

Y Chang-Qing, L Jie, Z Shi-Qi, Z Kun, G Zi-Qian… - Progress in biophysics …, 2020 - Elsevier
Breast cancer (BC) is a serious worldwide disease that threatens women's health.
Particularly, the morbidity of triple-negative breast cancer (TNBC) is higher than that of other …

Reprogrammed transsulfuration promotes basal-like breast tumor progression via realigning cellular cysteine persulfidation

K Erdélyi, T Ditrói, HJ Johansson… - Proceedings of the …, 2021 - National Acad Sciences
Basal-like breast cancer (BLBC) is the most aggressive subtype of breast tumors with poor
prognosis and limited molecular-targeted therapy options. We show that BLBC cells have a …